Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2016

May 9, 2016

30583_dirs_2016-05-09_5ff341fe-a685-496f-b834-2cf68356ad0c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-05-05

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-05 Common Stock M 10000 $12.99 Acquired 10000 Indirect
2016-05-05 Common Stock S 10000 $80.1489 Disposed 0 Indirect
2016-05-05 Common Stock M 10000 $12.99 Acquired 10000 Indirect
2016-05-05 Common Stock S 10000 $80.1489 Disposed 0 Indirect
2016-05-05 Common Stock M 10000 $12.99 Acquired 10000 Indirect
2016-05-05 Common Stock M 10000 $80.1489 Disposed 0 Indirect
2016-05-05 Common Stock M 10000 $12.99 Acquired 10000 Indirect
2016-05-05 Common Stock S 10000 $80.1489 Disposed 0 Indirect
2016-05-05 Common Stock M 20000 $12.99 Acquired 20000 Indirect
2016-05-05 Common Stock S 20000 $80.1489 Disposed 0 Indirect
2016-05-06 Common Stock F 5479 $80.80 Disposed 390156 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-05 Stock Option (right to buy) Common Stock $12.99 M 10000 Disposed 2016-05-10 Common Stock (10000) Indirect
2016-05-05 Stock Option (right to buy) Common Stock $12.99 M 10000 Disposed 2016-05-10 Common Stock (10000) Indirect
2016-05-05 Stock Option (right to buy) Common Stock $12.99 M 10000 Disposed 2016-05-10 Common Stock (10000) Indirect
2016-05-05 Stock Option (right to buy) Common Stock $12.99 M 10000 Disposed 2016-05-10 Common Stock (10000) Indirect
2016-05-05 Stock Option (right to buy) Common Stock $12.99 M 20000 Disposed 2016-05-10 Common Stock (20000) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 25758 Indirect

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 trading plan executed on August 17, 2015.

F2: The reporting person's spouse is the trustee of each child's trust.

F3: The price in column 4 is a weighted average price. The price actually received ranged from $79.46 to $82.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: Reflects the numbers of stock options outstanding after the transaction from this specific stock option grant.